Citation Tools
PDFPsoriatic arthritis
Original research
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies